Cargando…
Comparison of the analytical performance between the Oncomine Dx Target Test and a conventional single gene test for epidermal growth factor receptor mutation in non‐small cell lung cancer
BACKGROUND: Next‐generation sequencing (NGS) has been implemented in clinical oncology to analyze multiple genes and to guide targeted therapy; however, little is known about the performance of the Oncomine Dx Target Test compared with conventional single gene tests for detecting EGFR mutations. The...
Autores principales: | Sakaguchi, Tadashi, Iketani, Akemi, Furuhashi, Kazuki, Nakamura, Yuki, Suzuki, Yuta, Ito, Kentaro, Fujiwara, Kentaro, Nishii, Yoichi, Katsuta, Koji, Taguchi, Osamu, Hataji, Osamu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882374/ https://www.ncbi.nlm.nih.gov/pubmed/33314600 http://dx.doi.org/10.1111/1759-7714.13767 |
Ejemplares similares
-
Comparison of the analytical performance of the Oncomine dx target test focusing on bronchoscopic biopsy forceps size in non‐small cell lung cancer
por: Sakaguchi, Tadashi, et al.
Publicado: (2022) -
Clinical importance of the range of detectable variants between the Oncomine Dx target test and a conventional single-gene test for EGFR mutation
por: Sakaguchi, Tadashi, et al.
Publicado: (2023) -
A method to improve genetic analysis of lung cancer samples
por: Sakaguchi, Tadashi, et al.
Publicado: (2021) -
Good Response of Advanced Thymic Carcinoma with Low PD-L1 Expression to Chemotherapy plus Pembrolizumab as First-Line Therapy and to Pembrolizumab as Maintenance Therapy: A Case Report
por: Nishii, Yoichi, et al.
Publicado: (2022) -
Physical Activity Estimated by the Wearable Device in Lung Disease Patients: Exploratory Analyses of Prospective Observational Study
por: Ito, Kentaro, et al.
Publicado: (2023)